date:Nov 15, 2019
es in Europe, the US and the Eastern Asia as part of its long term growth plans.
The new facility complements ScotBios existing RD and head office facility at BioCity outside Glasgow and plays a key role in the businesss scaling up program.
This is a key stage in our stated business plan. A move to a larger facility was essential to allow us to increase production levels significantly and, importantly, to allow us to closely monitor the outcomes in a phased manner, says CEO Polly Van Alstyneat